“target of insomnia and anxiety“
Yes GC, it has been specifically developed for, and will be tested on, long term AVE shareholders.
If the phase 1 is succesful it will be rolled out to the broader market.
.
.
“target of insomnia and anxiety“Yes GC, it has been specifically...
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 40206670 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 52631350 | 28 |
View Market Depth
| Last trade - 14.57pm 20/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable